Mediclinic City Hospital designated as a Centre of Excellence in Surgical Proctology
This remarkable milestone was achieved under the leadership of Dr. Valentina Giaccaglia, Deputy Medical Director and Consultant Surgeon expert in Coloproctology and Pelvic Floor Diseases, who has also been honoured as the first female surgeon in the world to receive the SRC's Surgeon of Excellence in Surgical Proctology designation, a historic accomplishment and a testament to her work in the field.
The Centre of Excellence status reflects the collective efforts of a dedicated multidisciplinary team, comprising colorectal surgeons, gastroenterologists, radiologists, pathologists, physiotherapists, anaesthesiologists, specialised nursing staff and administrative support. Their integrated approach ensures every patient benefits from comprehensive, personalised, and evidence-based care.
Allae Almanini, Chief Operating Officer of Dubai Healthcare City Authority, said: 'We congratulate our strategic partner, Mediclinic City Hospital, for this notable recognition that underscores their persistent dedication to providing healthcare excellence and innovation. At DHCA, we are committed to fostering an enabling ecosystem where our partners can thrive, driving the advancement of high-quality, specialised healthcare services that enhance the well-being of community members across the UAE."
'This international recognition is a proud moment for Mediclinic City Hospital and the wider Mediclinic Middle East group,' said David Eglington, Hospital Director, Mediclinic City Hospital. 'It reflects the extraordinary commitment of Dr. Valentina and our multidisciplinary team to clinical excellence and innovation, and reinforces our position as a regional leader in specialised surgical care.'
Dr. Valentina added: 'Being recognised as a Centre of Excellence is the result of years of dedication to improving outcomes and quality of life for patients. It is a privilege to work alongside such a skilled and compassionate team.'
Mediclinic City Hospital remains committed to continuous improvement and delivering world-class outcomes by adhering to the highest international benchmarks.
About Mediclinic Middle East:
Mediclinic City Hospital provides international standard healthcare across a broad range of primary, secondary and tertiary services. It is operated by Mediclinic Middle East, which is part of Mediclinic Group, a diversified international private healthcare services group established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the UAE.
The foundation of Mediclinic lies in the application of rigorous science to improve the lives of patients, through the use of state-of-the-art treatments and technologies to care for patients in an evidence-based environment.
Mediclinic Middle East operates seven hospitals and 29 clinics with over 950 inpatient beds in the United Arab Emirates.
About Dubai Healthcare City:
Dubai Healthcare City (DHCC) was established in 2002 by His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and Ruler of Dubai. Governed by the Dubai Healthcare City Authority (DHCA), a Dubai Government entity, the free zone is Dubai's healthcare investment hub, attracting local and international investments to drive innovation and enhance healthcare delivery.
The enabling healthcare and wellness destination is the largest healthcare ecosystem in the region, operating at the intersection of healthcare, wellness, community living, and regulation. DHCC also facilitates business set-up across medical care, wellness, academic and research, as well as hosting pharmaceutical, medical equipment, and support service providers. These offerings are complemented with a selection of modern lifestyle options, providing the community visitors with a wide range of hospitality and leisure features.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Business
an hour ago
- Arabian Business
Abu Dhabi launches newborn genetic screening programme to detect 815 childhood conditions
The Department of Health – Abu Dhabi (DoH) has launched the Newborn Genetic Screening Programme, one of the most comprehensive of its kind globally, offering whole genome sequencing to screen for more than 815 treatable childhood genetic conditions. The initiative, launched in alignment with the Emirati Genome Council's vision for personalised and precision healthcare, marks a step towards genomics-driven medicine in the UAE. It enables early detection, tailored interventions, and improved health outcomes for newborns. In its first phase, the programme has been introduced at Kanad Hospital and Danat Al Emarat Hospital, in partnership with M42, as a voluntary option. It is set to expand across all maternity hospitals in the emirate to cover UAE nationals and children of Emirati mothers. By testing cord blood samples at birth with parental consent, the programme screens for metabolic disorders, immunodeficiencies, hematologic conditions, and rare diseases such as spinal muscular atrophy, which can be treated with gene therapy. Dr. Noura Khamis Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi, said: 'Healthcare begins long before symptoms appear, and today, empowered by science and technology, we can act earlier than ever before. This programme reflects Abu Dhabi's commitment to leveraging innovation to serve our community, starting from the first days of life. Through early detection, personalised care, and strategic foresight, we are building a future of healthier generations and reinforcing Abu Dhabi's position as a global leader in proactive, precision healthcare.' Dr. Mohamed Al Ameri, Acting Director of Genome and Biobank Division, Department of Health – Abu Dhabi, said: 'As we work to integrate genomics into our preventative healthcare infrastructure, we aim to expand this initiative to all maternity hospitals in the emirate, demonstrating how genomics can reshape healthcare, shifting from a one-size-fits-all model to a precise, proactive, and personalised approach that improves patient outcomes.' To support the rollout, DoH held workshops with stakeholders to review the gene panel and patient journey, and trained 16 paediatricians and neonatologists on genetic counselling practices. Results are reported within 21 days, with genetic counselling and referrals provided if actionable findings are identified. The Newborn Genetic Screening Programme builds on initiatives under the Emirati Genome Programme, including premarital screening, and is part of a broader strategy to integrate genomics into family health to reduce the prevalence of genetic diseases and support informed decision-making.
Economy ME
4 hours ago
- Economy ME
Jordan sees record growth in medical tourism with over 92,000 visitors by May 2025
Jordan is solidifying its status as the Middle East and North Africa (MENA) region's leading medical tourism destination, recording a remarkable rise in patient arrivals seeking both advanced medical care and natural therapeutic treatments. During the first seven months of 2025, the country witnessed a record increase in medical tourist arrivals, building on steady growth over the past three years. In 2024, over 224,000 medical tourists visited Jordan — up from 202,592 in 2023 and 191,532 in 2022 — demonstrating consistent upward momentum. The growth is powered by two major factors: An expanding range of specialized healthcare services, supported by a highly skilled medical workforce, and the country's natural healing environments like the Dead Sea and Ma'in Hot Springs. Jordan has an expanding range of specialized healthcare services, supported by a highly skilled medical workforce Read: UAE leads in accredited healthcare facilities globally, allocates $1.57 billion for 2025 services A booming global industry Jordan's growth in medical tourism comes amid a global surge in demand for cross-border healthcare . The global medical tourism market, valued at $31.23 – 41.79 billion in 2024, is projected to reach over $160 billion by 2032. The MENA region, particularly GCC countries, has traditionally been a major source of outbound medical travelers. Kuwait sends around 650 patients per month abroad, incurring $1 billion annually, while Saudi Arabia's Health Ministry reported 2,400 patients treated overseas, costing $800 million. Jordan's ability to attract these outbound patients has transformed the country into a regional hub for inbound medical tourism, generating over $1 billion in annual revenue, which contributes approximately 4 percent to Jordan's GDP. 'Our medical tourism sector has a legacy that dates back to the 1970s, when Jordan emerged as one of the top destinations for medical care in the region. The sector is continuing to demonstrate exceptional growth as a preferred therapeutic destination both regionally and globally,' said Dr. Abdelrazzak Arabiyat, managing director of the Jordan Tourism Board. 'The growth in medical tourism is primarily driven by the world-class healthcare services that our hospitals offer, the popularity of the natural therapeutic sites and the renowned hospitality of our country. 'What sets the country's medical tourism sector apart are the cost-effective yet high quality care assured within the country and the diverse natural attractions that add to the well-being of the patients and those who accompany them,' Dr. Arabiyat added. Record-breaking visitor numbers in 2025 In just the first quarter of 2025, Jordan welcomed 51,448 medical tourists, which rose to 92,776 by the end of May, marking a 16.5 percent increase compared to the same period last year. The country is on track to surpass previous records and set a new benchmark for its healthcare tourism sector. Jordan continues to attract patients primarily from Iraq, Saudi Arabia, Palestine, Syria, Yemen, Libya, and other GCC countries, drawn by the nation's quality healthcare, affordability, and cultural proximity. Jordan's growth in medical tourism comes amid a global surge in demand for cross-border healthcare World-class healthcare at competitive prices Jordan's medical care offers substantial cost advantages. Treatments are estimated to be 25 percent to 40 percent cheaper than in the US and Europe, and 5 percent to 10 percent lower than in medical tourism leaders like India, Singapore, and Thailand. The country boasts over 120 hospitals and medical centers, including 71 private and 47 public institutions. Many of these are internationally accredited by bodies such as the Joint Commission International (JCI) and the Health Care Accreditation Council (HCAC), assuring high standards of care and patient safety. Advanced medical capabilities and historic milestones Jordan has been a medical pioneer in the region, performing the first open-heart surgery in 1970 and the first kidney transplant in 1972. The King Hussein Cancer Center (KHCC) remains one of the region's most advanced oncology institutions, completing 250 bone marrow transplants in 2022 with a success rate of over 85 percent, matching international benchmarks. Top hospitals attracting medical tourists include: Jordan Hospital Specialty Hospital Abdali Hospital Al-Kindi Hospital Ibn Al-Haytham Hospital Arab Medical Center King Hussein Cancer Center In the public sector, leading institutions include Royal Medical Services (Medical City) and Al-Bashir Hospital. The country's medical workforce exceeds 30,000 professionals, many of whom are Western-educated and board-certified, offering services in specialties like cardiology, oncology, orthopedics, and fertility. Short waiting times and the widespread use of English among medical professionals further enhance patient confidence and comfort. Natural therapeutic destinations Complementing Jordan's medical infrastructure are unique natural healing sites that support patient recovery: Dead Sea: The lowest point on Earth (400 meters below sea level), offering mineral-rich waters with 33 percent salt content known for treating skin, joint, and respiratory conditions. Ma'in Hot Springs: Featuring thermal waterfalls up to 60°C, known for benefits in treating skin disorders, arthritis, and circulatory issues. These natural resources offer a distinctive recovery experience that combines modern medicine with ancient therapeutic traditions. What sets Jordan's medical tourism sector apart are the cost-effective yet high quality care Strong economic contribution Medical tourism is a significant pillar of Jordan's economy, not only generating over $1 billion annually but also creating thousands of jobs and supporting related sectors such as hospitality, transport, and translation services. Medical tourists are estimated to spend 3 to 5 times more than leisure travelers due to longer stays and broader service needs. Jordan's well-developed hospitality infrastructure, with accommodation options, patient transport, and multilingual support, ensures a smooth experience for international patients and their companions. 'The diversity of medical specialties available in Jordan, combined with our natural therapeutic destinations and skilled healthcare professionals, has created a strong and sustainable medical tourism ecosystem,' Dr Arabiyat said. 'Over the years, we have been focused on promoting our strengths in medical tourism through targeted digital ad campaigns, promotional videos and FAM trips for media and medical delegations, all contributing to the popularity of the country for world-class medical care.' As demand for global healthcare options grows, Jordan is well-positioned to lead the MENA region in offering high-quality, affordable, and holistic medical care. Backed by robust infrastructure, medical expertise, and natural therapeutic advantages, the country continues to elevate its reputation as a premier global medical tourism destination.
Zawya
5 hours ago
- Zawya
Cleveland Clinic Abu Dhabi introduces breakthrough stroke treatment
Cleveland Clinic Abu Dhabi has performed the region's first procedure using the Artisse Intrasaccular Flow Modulator, a pioneering medical implant for treating wide-necked brain aneurysms. Designated by the Department of Health – Abu Dhabi as a Centre of Excellence for stroke, the hospital is the first in the Middle East and North Africa to adopt the technology. The minimally invasive procedure involves inserting a catheter through a blood vessel to deploy a mesh device that seals the aneurysm, preventing rupture and reducing the risk of stroke. The first patient treated with the device at the hospital showed successful aneurysm closure after three months, underscoring the technology's potential for safer and more effective outcomes. Fayeza Al Yafie, Executive Director of Healthcare Quality at the Department of Health – Abu Dhabi, said the milestone reflects the emirate's commitment to innovation and advanced patient care. Khalil Zahra, Staff Physician in Neurosurgery at Cleveland Clinic Abu Dhabi, said the new approach enhances treatment for complex aneurysms while reducing the need for invasive surgery. Since launching the UAE's first multi-organ transplant programme in 2017, Cleveland Clinic Abu Dhabi has become a leading referral centre for advanced care. The adoption of this device further strengthens its role as a hub for neurological innovation in the region.
